His research projects include the epidemiology, risk factors, pathogenesis, central nervous system involvement and treatment of diabetic neuropathy and neuropathic pain. He has published a book, over 150 original articles, reviews and book chapters in the field of diabetic neuropathy including a landmark study in the New England Journal of Medicine. Professor Tesfaye was awarded the Prestigious Camillo Golgi Prize of the EASD in 2014 for major scientific contributions in Diabetic Neuropathy. Prof. Tesfaye has had international leadership roles including chairmanship of the International Expert Group on Diabetic Neuropathy that published 7 consensus recommendation papers in 2010/11, and of NEURODIAB (2006-9) which is the largest diabetic neuropathy scientific group in the world. He is also a member of the Science and Research Committee of Diabetes UK; a review panel member for the Medical Research Council (MRC)’s Developmental Pathway Funding Scheme (2015-8), a Board Member of the Global Quantitative Sensation Testing Society; a member of the Advisory Council of the Neuropathy Trust and Secretary of International Insulin Foundation. He is also currently a member of the international Editorial Board of the Lancet Diabetes and Endocrinology, and the Associate Editor of: Experimental Diabetes Research, Frontiers in Endocrinology, European Endocrinology and Diabetes Management and was previous Associate Editor of Diabetologia. Professor Tesfaye is a Commissioner for the Lancet Diabetes & Endocrinology on Diabetes in Sub Saharan Africa and has served as a member of the MRC, JDRF, NIDDK, and UK NIHR (HTA, RfPB, EME) scientific review panels and as a member of a Diabetes & Neuropathic pain Review Group for the National Institute for Clinical Excellence (NICE 2010,13).